Video
Clinical care pathway demonstrates efficacy for patients with overactive bladder
Author(s):
Chris Du, MD, discusses findings from a study published in Neurourology and Urodynamics.
Video Player is loading.
In this interview, Chris Du, MD, discusses findings from the Neurourology and Urodynamics paper, A retrospective longitudinal evaluation of new overactive bladder patients in an FPMRS urologist practice: Are patients following up and utilizing third‐line therapies?, for which he served as a study author. Du is a urology resident at Stony Brook University, Stony Brook, New York.
More videos:
Analysis underscores importance of pretreatment urine cultures in patients with recurrent UTI
A primer for urologists on statutes of limitations
Related Videos
Ekene Enemchukwu, MD, on underutilization of vaginal estrogen for GSM
Sima Porten, MD, on gene-environment interactions in bladder cancer development
Naeem Bhojani, MD, expands on key findings from WATER III trial
Hailey Frye discusses improvement of pain management for nephrolithiasis
Ekene Enemchukwu, MD, on trends in vaginal estrogen use for GSM
How rBCG EAP could open up access for Anktiva in bladder cancer
Betty Wang, MD, recaps 3 key urologic cancer studies from EAU 2025
Neeraj Agarwal, MD, on the safety profile of talazoparib/enzalutamide in mCRPC
Anna Myers, CNP, discusses her approach to preventing UTIs
Joshua J. Meeks, MD, PhD, discusses the impact of neoadjuvant durvalumab approval in MIBC
Related Content
